Yulin Zou

Goettingen, NI, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Comment on 'Nail matrix melanoma in adolescents and young adults: a retrospective dermoscopic study': Do observations justify revision of diagnostic criteria?

Comment on 'Nail matrix melanoma in adolescents and young adults: a retrospective dermoscopic study': Do observations justify revision of diagnostic criteria?

Journal: Clinical and experimental dermatology

Published: June 08, 2026

Comment on 'Clinicopathological features and treatment outcomes of fibrosing alopecia in a pattern distribution: a multicentre cohort study': Does observed stabilization necessarily reflect disease control?

Comment on 'Clinicopathological features and treatment outcomes of fibrosing alopecia in a pattern distribution: a multicentre cohort study': Does observed stabilization necessarily reflect disease control?

Journal: Clinical and experimental dermatology

Published: June 08, 2026

Comment on 'Risk of inflammatory dermatoses following COVID-19 infection: a cohort study of 204,241 patients': considerations regarding causal inference.

Comment on 'Risk of inflammatory dermatoses following COVID-19 infection: a cohort study of 204,241 patients': considerations regarding causal inference.

Journal: Clinical and experimental dermatology

Published: May 31, 2026

Comment on 'Testing patterns, patient and tumour characteristics and survival by NRAS and KIT genotype in melanoma': can survival associations be inferred from selectively tested populations?

Comment on 'Testing patterns, patient and tumour characteristics and survival by NRAS and KIT genotype in melanoma': can survival associations be inferred from selectively tested populations?

Journal: Clinical and experimental dermatology

Published: May 31, 2026

Comment on 'Lebrikizumab provides stable skin response with no or minimal fluctuations for up to 2 years in patients with atopic dermatitis': Does persistence among responders equal durable disease control?

Comment on 'Lebrikizumab provides stable skin response with no or minimal fluctuations for up to 2 years in patients with atopic dermatitis': Does persistence among responders equal durable disease control?

Journal: Clinical and experimental dermatology

Published: May 31, 2026

Herpes zoster, antiviral therapy, and Alzheimer's disease: Turning association into an actionable prevention pathway.

Herpes zoster, antiviral therapy, and Alzheimer's disease: Turning association into an actionable prevention pathway.

Journal: Journal of Alzheimer's disease : JAD

Published: April 03, 2026

A Global Study of Skin and Subcutaneous Diseases Among Individuals Under 20 Years of Age.

A Global Study of Skin and Subcutaneous Diseases Among Individuals Under 20 Years of Age.

Journal: Clinical, cosmetic and investigational dermatology

Published: February 06, 2026

Comment on: "Characterization and analysis of the skin mycobiome in keloid: A case-control study".

Comment on: "Characterization and analysis of the skin mycobiome in keloid: A case-control study".

Journal: Burns : journal of the International Society for Burn Injuries

Published: January 12, 2026

Comment on 'Drug survival, effectiveness and safety of risankizumab for moderate-to-severe psoriasis for up to 4 years': clarifying drug survival metrics and capturing joint outcomes.

Comment on 'Drug survival, effectiveness and safety of risankizumab for moderate-to-severe psoriasis for up to 4 years': clarifying drug survival metrics and capturing joint outcomes.

Journal: Clinical and experimental dermatology

Published: January 04, 2026

Deciphering MAPK dependence in epidermolysis bullosa-associated squamous cell carcinoma: Toward biomarker-guided MEK inhibition.

Deciphering MAPK dependence in epidermolysis bullosa-associated squamous cell carcinoma: Toward biomarker-guided MEK inhibition.

Journal: The Journal of investigative dermatology

Published: December 29, 2025

Comment on "Educational impact of a cost-efficient burns excision and skin grafting porcine simulation model".

Comment on "Educational impact of a cost-efficient burns excision and skin grafting porcine simulation model".

Journal: Burns : journal of the International Society for Burn Injuries

Published: December 27, 2025

Comment on "Cancer progression, recurrence, and infection outcomes in psoriasis patients with active or recent malignancy treated with biologic therapy".

Comment on "Cancer progression, recurrence, and infection outcomes in psoriasis patients with active or recent malignancy treated with biologic therapy".

Journal: Journal of the American Academy of Dermatology

Published: December 26, 2025

Showing 1-12 of 23

Last Updated: 09/26/2026